Welcome to the P3 to PIII newsletter: timely news from MTIP to help you leverage public-private partnership (P3) opportunities through the SBIR/STTR programs and prepare you for Phase III commercialization success MTIP Summer SBIR Webinar Series: National Science Foundation SBIR/STTR Funding with special guest NSF SBIR/STTR program director, Rick Schwerdtfeger Join us from anywhere to learn about […]
Learn from your peers with a live case study featuring Ron Zook, CEO & Founder of Swan Valley Medical talking about his experience with technology commercialization, product development, scaling and more. TechEx team member, Toni Tease, Daniel Juliano, Director of the Technology Transfer Office at MSU, and Ann Peterson , SBIR Outreach Program manager, will […]
A research center at the University of Montana earned $22.4 million this summer and fall from the National Institutes of Health. “It’s validated that what we set up in Missoula through this Center for Translational Medicine is working to advance discoveries at the University of Montana,” said Jay Evans, center director and research professor in […]
A Montana State University technology anticipated to improve the accuracy of medical diagnoses has been licensed by FYR Diagnostics, a biotech company in Missoula. The license agreement transfers to FYR Diagnostics a molecule detection technology developed by Stephanie McCalla, assistant professor in MSU’s Chemical and Biological Engineering Department, and Tomas Gedeon, professor in the Department of Mathematical Sciences. […]
Prepare Your 2018 Omnibus Solicitation Application for Small Business Innovation Research and Technology Transfer Grants Application deadline: Sept. 5, 2018, 5:00 p.m. local time The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 […]
The New York Times editorial board recently observed: “We shouldn’t be surprised by any biotech’s failure. We should expect it. Biotechs by their nature offer the promise of disruptive breakthroughs and discoveries, but they’re mostly all-in propositions, based on one molecule or one test. Fail in a Phase III clinical trial — and a majority do — […]
Smithsonian magazine publishes story about impact of MSU alum, vaccinologist Maurice Hilleman From MSU News Service FEBRUARY 23, 2018 BOZEMAN — The work and impact of a Montana State University alumnus was featured recently in a prominent national forum. “You Should Thank Maurice Hilleman for Helping You Live Past the Age of 10”was published […]
